CCRN — what changed in the latest 10-Q
A section-by-section comparison of CCRN's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-08 vs the prior 10-Q · 2025-11-12
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +23 | −46 | ~17 | 11 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~2 | 1 |
| Controls & procedures | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | Some risk factors updated | +1 | −5 | 0 | 0 |
| Other information | Text added/removed | +3 | −2 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-08
On May 6, 2026, the Company entered into an Agreement and Plan of Merger with KL Criss Cross Intermediate, LLC, a Delaware corporation (Parent), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (Merger Sub), pursuant to which Merger Sub will merge w…
For the quarter ended March 31, 2026, consolidated revenue decreased 17.8% year-over-year to $241.1 million, primarily due to volume declines in the Nurse and Allied Staffing and Physician Staffing segments. These declines were partly offset by continued growth in Cross Country Community Care, which…
For the three months ended March 31, 2026, cash and cash equivalents totaled $105.6 million. During the first quarter, the Company repurchased 657,653 shares under the Repurchase Program (as defined below). Cash flow provided by operating activities for the three months ended March 31, 2026 was $4.8…
Comparison of Results for the Three Months Ended March 31, 2026 and the Three Months Ended March 31, 2025
Revenue from services decreased 17.8% to $241.1 million for the three months ended March 31, 2026, as compared to $293.4 million for the three months ended March 31, 2025, primarily due to volume declines in the Nurse and Allied Staffing and Physician Staffing segments. See further discussion in Seg…
Text removed vs the prior filing · source: 10-Q · 2025-11-12
For the quarter ended September 30, 2025, consolidated revenue declined 20.6% year-over-year to $250.1 million, primarily due to volume declines in the Nurse and Allied Staffing and Physician Staffing segments. These declines were partly offset by continued growth in Homecare Staffing, which was up …
For the three months ended September 30, 2025, cash and cash equivalents totaled $99.1 million. Cash flow provided by operating activities for the three months ended September 30, 2025 was $20.1 million. As of September 30, 2025, there were no borrowings drawn under the revolving senior-secured asse…
On December 3, 2024, Cross Country entered into an Agreement and Plan of Merger (Merger Agreement) with Aya Holdings II Inc., a Delaware corporation (Parent), Spark Merger Sub One Inc., a Delaware corporation and a wholly owned subsidiary of Parent (Merger Sub), and, solely for purposes of Section 1…
Selling, general and administrative expenses18.8 17.2 18.3 17.2
Comparison of Results for the Three Months Ended September 30, 2025 and the Three Months Ended September 30, 2024
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-05-08
Except as set forth above in Information Relating to Forward-Looking Statements, there have been no material changes to the risk factors previously disclosed in Part I, Item 1A of the Company’s 2025 Form 10‑K.
Text removed vs the prior filing · source: 10-Q · 2025-11-12
In addition to the other information set forth in this report, careful consideration should be given to the factors discussed in Item1 A, “Risk Factors” in our 2024 Form 10-K, all of which could materially affect our business, financial condition, or future results. The risk described herein and the…
If closing of the Aya Merger is delayed or does not occur, the Company’s business and stock price may be adversely affected.
The consummation of the Aya Merger is subject to the satisfaction of a number of closing conditions, including, without limitation, the successful completion of a review by the U.S. Federal Trade Commission (FTC) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). The Company a…
We are not able to predict when or if the Aya Merger will be consummated. Any extended delay in the consummation of the Aya Merger, uncertainty of the closing, or if the Aya Merger ultimately is not consummated, could adversely affect the Company’s business. Specifically, if the Aya Merger is not co…
In addition, if the Aya Merger is not consummated, the Company’s stock price may decline to the extent that the current market price reflects a market assumption that the Aya Merger will be completed. Accordingly, if the Aya Merger is not completed, there can be no assurance as to the effect of thes…
Other information
Text added vs the prior filing · source: 10-Q · 2026-05-08
As previously disclosed in the Company’s Current Report on Form 8-K filed with the SEC on May 6, 2026, the Board has determined to cancel the Company’s 2026 Annual Meeting of Stockholders (2026 Annual Meeting), which was previously scheduled to be held virtually on May 11, 2026, and to withdraw from…
arrangement or non-Rule 10b5-1 trading arrangement (as that term is defined in Item 408(c) of Regulation S-K) during the most recently completed quarter.
During the three months ended March 31, 2026 neither the Company nor any of its Section 16 officers or directors adopted, modified, or terminated any contract, instruction, or written plan for the purchase or sale of the Company’s securities, under either a Rule 10b5-1 trading arrangement or a non-R…
Text removed vs the prior filing · source: 10-Q · 2025-11-12
As previously disclosed in the Company’s Current Report on Form 8-K filed with the SEC on September 30, 2025 (September 30th Form 8-K), the Company’s 2025 Annual Meeting of Stockholders (Annual Meeting) will be held on December 9, 2025, which is more than 30 days after the anniversary of the Company…
During the three months ended September 30, 2025, neither the Company nor any of its Section 16 officers or directors adopted, modified, or terminated any contract, instruction, or written plan for the purchase or sale of the Company’s securities, under either a Rule 10b5-1 trading arrangement or a …
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice